Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Targeting the ORigin of the Inflammatory Cascade in Allergic Asthma: Cross-talk Between Airway Epithelium and Immune Cells

NCT04264377 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT04264377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04264377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Targeting the ORigin of the Inflammatory Cascade in Allergic Asthma: Cross-talk Between Airway Epithelium and Immune Cells
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Unknown status
Start date
February 7, 2020
Completion date
December 31, 2022
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma, asthma